Owkinews: what happened in July
Owkin K will create AI agents to work with our data scientists on decoding the complexities of the immune system. This project will drive forward AI research and shape the future of drug discovery, development, and diagnostics.
Owkin x STAT webinar: Is this the era of AI diagnostics?
Watch our event featuring pharmaceutical, clinical, and AI experts discussing the impact of AI diagnostics on industry and patients.
Introducing TLS Detect RUO
TLS Detect is an AI tool that identifies tertiary lymphoid structures (TLS) in tumors, using digital H&E slides. This solution has been developed with data from the Cancer Comprehensive Center and Institut Bergonié.
TLS is a biomarker for assessing survival risk and immunotherapy response in untreated cancer patients.
Blog 2 in our Dx series: the importance of data in building an AI diagnostic
In this blog, jump into how Owkin’s MSIntuit® CRC diagnostic works with whole slide images, and how it provides a digital pathology prescreen approach to pathologists and oncologists.